Almeida, L., Loureiro, A. I., Vaz-Da-Silva, M., Torrão, L., et al. (2010). Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor. Current Medical Research and Opinion, 26(5), 1097 - 1108.

Vaz-Da-Silva, M., Almeida, L., Falcão, A., Soares, E., et al. (2010). Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study. Clinical therapeutics, 32(1), 179 - 192.

Castro, A., Lemos, C., Falcão, A., Fernandes, A. S., et al. (2010). Rotenone enhances the antifungal properties of staurosporine. Eukaryotic Cell, 9(6), 906 - 914.

Almeida, L., Vaz-Da-Silva, M., Falcão, A., Soares, E., et al. (2009). Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Molecular Nutrition and Food Research, 53(SUPPL. 1), S7 - S15.

Almeida, L., Falcão, A., Vaz-Da-Silva, M., Nunes, T., et al. (2008). Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. European Journal of Clinical Pharmacology, 64(10), 961 - 966.

Castro, A., Lemos, C., Falcão, A., Glass, N. L., & Videira, A. (2008). Increased resistance of complex I mutants to phytosphingosine-induced programmed cell death. Journal of Biological Chemistry, 283(28), 19314 - 19321.

Almeida, L., Falcão, A., Vaz-Da-Silva, M., Coelho, R., et al. (2008). Personality characteristics of volunteers in phase 1 studies and likelihood of reporting adverse events. International Journal of Clinical Pharmacology and Therapeutics, 46(7), 340 - 348.

Vaz-Da-Silva, M., Loureiro, A. I., Nunes, T., Lopes, C., et al. (2008). Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-O-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg: Randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Drugs in R and D, 9(6), 435 - 446.